Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

The global epidemiology of viral-induced acute liver failure: a systematic review protocol.

Patterson J, Hussey HS, Abdullahi LH, Silal S, Goddard L, Setshedi M, Spearman W, Hussey GD, Kagina B, Muloiwa R.

BMJ Open. 2019 Aug 30;9(8):e029819. doi: 10.1136/bmjopen-2019-029819.

2.

A systematic review of the epidemiology of hepatitis A in Africa.

Patterson J, Abdullahi L, Hussey GD, Muloiwa R, Kagina BM.

BMC Infect Dis. 2019 Jul 22;19(1):651. doi: 10.1186/s12879-019-4235-5.

3.

Assessment of humoral and cell-mediated immune responses to pertussis vaccination: a systematic review protocol.

Akinola F, Muloiwa R, Hussey GD, Dirix V, Kagina B, Amponsah-Dacosta E.

BMJ Open. 2019 Jun 9;9(6):e028109. doi: 10.1136/bmjopen-2018-028109.

4.

Hepatitis A seroprevalence in Western Cape Province, South Africa: Are we in epidemiological transition?

Enoch A, Hardie DR, Hussey GD, Kagina BM.

S Afr Med J. 2019 Apr 29;109(5):314-318. doi: 10.7196/SAMJ.2019.v109i5.13410.

5.

Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: A systematic review.

Patterson J, Kagina BM, Gold M, Hussey GD, Muloiwa R.

Vaccine. 2018 Sep 25;36(40):6007-6016. doi: 10.1016/j.vaccine.2018.08.022. Epub 2018 Aug 22.

6.

Comparison of school based and supplemental vaccination strategies in the delivery of vaccines to 5-19 year olds in Africa - a systematic review.

Haddison EC, Abdullahi LH, Muloiwa R, Hussey GD, Kagina BM.

F1000Res. 2017 Oct 13;6:1833. doi: 10.12688/f1000research.12804.1. eCollection 2017.

7.

Adverse events following primary and secondary immunisation with whole-cell pertussis: a systematic review protocol.

Patterson J, Kagina BM, Gold M, Hussey GD, Muloiwa R.

BMJ Open. 2017 Jan 25;7(1):e012945. doi: 10.1136/bmjopen-2016-012945.

8.

Public stewardship of private for-profit healthcare providers in low- and middle-income countries.

Wiysonge CS, Abdullahi LH, Ndze VN, Hussey GD.

Cochrane Database Syst Rev. 2016 Aug 11;(8):CD009855. doi: 10.1002/14651858.CD009855.pub2. Review.

9.

The Cape Town Declaration on Vaccines 2012: Unlocking the full potential of vaccines in Africa.

Wiysonge CS, Waggie Z, Hawkridge A, Schoub BD, Madhi SA, Rees H, Hussey GD; delegates of the first International African Vaccinology Conference.

Vaccine. 2016 Jul 19;34(33):3713-4. doi: 10.1016/j.vaccine.2016.05.072. Epub 2016 Jun 15.

PMID:
27317265
10.

Knowledge, attitudes and practices on adolescent vaccination among adolescents, parents and teachers in Africa: A systematic review.

Abdullahi LH, Kagina BM, Cassidy T, Adebayo EF, Wiysonge CS, Hussey GD.

Vaccine. 2016 Jul 25;34(34):3950-60. doi: 10.1016/j.vaccine.2016.06.023. Epub 2016 Jun 8. Review.

PMID:
27289251
11.

Human newborn bacille Calmette-Guérin vaccination and risk of tuberculosis disease: a case-control study.

Fletcher HA, Filali-Mouhim A, Nemes E, Hawkridge A, Keyser A, Njikan S, Hatherill M, Scriba TJ, Abel B, Kagina BM, Veldsman A, Agudelo NM, Kaplan G, Hussey GD, Sekaly RP, Hanekom WA; BCG study team.

BMC Med. 2016 May 16;14:76. doi: 10.1186/s12916-016-0617-3.

12.

Varicella zoster virus-associated morbidity and mortality in Africa: a systematic review protocol.

Hussey HS, Abdullahi LH, Collins JE, Muloiwa R, Hussey GD, Kagina BM.

BMJ Open. 2016 Apr 20;6(4):e010213. doi: 10.1136/bmjopen-2015-010213.

13.

A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups.

Lancet. 2016 Jun 4;387(10035):2312-2322. doi: 10.1016/S0140-6736(15)01316-1. Epub 2016 Mar 24.

14.

Incidence and Diagnosis of Pertussis in South African Children Hospitalized With Lower Respiratory Tract Infection.

Muloiwa R, Dube FS, Nicol MP, Zar HJ, Hussey GD.

Pediatr Infect Dis J. 2016 Jun;35(6):611-6. doi: 10.1097/INF.0000000000001132.

PMID:
26967813
15.

Epidemiology of hepatitis A virus in Africa among persons aged 1-10 years: a systematic review protocol.

Kanyenda TJ, Abdullahi LH, Hussey GD, Kagina BM.

Syst Rev. 2015 Sep 26;4:129. doi: 10.1186/s13643-015-0112-5.

16.

The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children.

Mulenga H, Tameris MD, Luabeya KK, Geldenhuys H, Scriba TJ, Hussey GD, Mahomed H, Landry BS, Hanekom WA, McShane H, Hatherill M.

Pediatr Infect Dis J. 2015 Nov;34(11):1157-62. doi: 10.1097/INF.0000000000000847.

17.

First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.

Luabeya AK, Kagina BM, Tameris MD, Geldenhuys H, Hoff ST, Shi Z, Kromann I, Hatherill M, Mahomed H, Hanekom WA, Andersen P, Scriba TJ; H56-032 Trial Study Group, Schoeman E, Krohn C, Day CL, Africa H, Makhethe L, Smit E, Brown Y, Suliman S, Hughes EJ, Bang P, Snowden MA, McClain B, Hussey GD.

Vaccine. 2015 Aug 7;33(33):4130-40. doi: 10.1016/j.vaccine.2015.06.051. Epub 2015 Jun 19.

PMID:
26095509
18.
19.

Increasing the value of health research in the WHO African Region beyond 2015--reflecting on the past, celebrating the present and building the future: a bibliometric analysis.

Uthman OA, Wiysonge CS, Ota MO, Nicol M, Hussey GD, Ndumbe PM, Mayosi BM.

BMJ Open. 2015 Mar 13;5(3):e006340. doi: 10.1136/bmjopen-2014-006340. Review.

20.

A bibliometric analysis of cancer research in South Africa: study protocol.

Moodley J, Singh V, Kagina BM, Abdullahi L, Hussey GD.

BMJ Open. 2015 Feb 12;5(2):e006913. doi: 10.1136/bmjopen-2014-006913.

21.

Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry.

Kagina BM, Mansoor N, Kpamegan EP, Penn-Nicholson A, Nemes E, Smit E, Gelderbloem S, Soares AP, Abel B, Keyser A, Sidibana M, Hughes JE, Kaplan G, Hussey GD, Hanekom WA, Scriba TJ.

J Immunol Methods. 2015 Feb;417:22-33. doi: 10.1016/j.jim.2014.12.003. Epub 2014 Dec 16.

22.

The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses.

Kagina BM, Tameris MD, Geldenhuys H, Hatherill M, Abel B, Hussey GD, Scriba TJ, Mahomed H, Sadoff JC, Hanekom WA; 018-402 Clinical Lab study team, Mansoor N, Hughes J, de Kock M, Whatney W, Africa H, Krohn C, Veldsman A, Kany AL, Douoguih M, Pau MG, Hendriks J, McClainc B, Benko J, Snowden MA, Hokey DA.

Vaccine. 2014 Oct 14;32(45):5908-17. doi: 10.1016/j.vaccine.2014.09.001. Epub 2014 Sep 10.

PMID:
25218194
23.

Safety of licensed vaccines in HIV-infected persons: a systematic review protocol.

Kagina BM, Wiysonge CS, Lesosky M, Madhi SA, Hussey GD.

Syst Rev. 2014 Sep 11;3:101. doi: 10.1186/2046-4053-3-101.

24.

Knowledge, attitudes and practices on adolescent vaccination among parents, teachers and adolescents in Africa: a systematic review protocol.

Abdullahi LH, Kagina BM, Cassidy T, Adebayo EF, Wiysonge CS, Hussey GD.

Syst Rev. 2014 Sep 9;3:100. doi: 10.1186/2046-4053-3-100.

25.

The use of supplementary immunisation activities to improve uptake of current and future vaccines in low-income and middle-income countries: a systematic review protocol.

Kagina BM, Wiysonge CS, Machingaidze S, Abdullahi LH, Adebayo E, Uthman OA, Hussey GD.

BMJ Open. 2014 Feb 18;4(2):e004429. doi: 10.1136/bmjopen-2013-004429.

26.

Trends in the types and quality of childhood immunisations research output from Africa 1970-2010: mapping the evidence base.

Machingaidze S, Hussey GD, Wiysonge CS.

BMC Health Serv Res. 2014 Feb 4;14:52. doi: 10.1186/1472-6963-14-52.

27.

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review.

Nglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS.

BMC Infect Dis. 2013 Dec 2;13:566. doi: 10.1186/1471-2334-13-566. Review.

28.

Understanding interventions for improving routine immunization coverage in children in low- and middle-income countries: a systematic review protocol.

Machingaidze S, Rehfuess E, von Kries R, Hussey GD, Wiysonge CS.

Syst Rev. 2013 Nov 21;2:106. doi: 10.1186/2046-4053-2-106.

29.

TB incidence in an adolescent cohort in South Africa.

Mahomed H, Ehrlich R, Hawkridge T, Hatherill M, Geiter L, Kafaar F, Abrahams DA, Mulenga H, Tameris M, Geldenhuys H, Hanekom WA, Verver S, Hussey GD.

PLoS One. 2013;8(3):e59652. doi: 10.1371/journal.pone.0059652. Epub 2013 Mar 22.

30.

Strengthening the expanded programme on immunization in Africa: looking beyond 2015.

Machingaidze S, Wiysonge CS, Hussey GD.

PLoS Med. 2013;10(3):e1001405. doi: 10.1371/journal.pmed.1001405. Epub 2013 Mar 19. No abstract available.

31.
32.

Screening for TB in high school adolescents in a high burden setting in South Africa.

Mahomed H, Ehrlich R, Hawkridge T, Hatherill M, Geiter L, Kafaar F, Abrahams DA, Mulenga H, Tameris M, Geldenhuys H, Hanekom WA, Verver S, Hussey GD.

Tuberculosis (Edinb). 2013 May;93(3):357-62. doi: 10.1016/j.tube.2013.02.007. Epub 2013 Mar 7.

PMID:
23477938
33.

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial.

Tameris MD, Hatherill M, Landry BS, Scriba TJ, Snowden MA, Lockhart S, Shea JE, McClain JB, Hussey GD, Hanekom WA, Mahomed H, McShane H; MVA85A 020 Trial Study Team.

Lancet. 2013 Mar 23;381(9871):1021-8.

34.

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol.

Nglazi MD, Bekker LG, Wood R, Hussey GD, Wiysonge CS.

Syst Rev. 2013 Jan 16;2:6. doi: 10.1186/2046-4053-2-6.

35.

Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults.

Day CL, Tameris M, Mansoor N, van Rooyen M, de Kock M, Geldenhuys H, Erasmus M, Makhethe L, Hughes EJ, Gelderbloem S, Bollaerts A, Bourguignon P, Cohen J, Demoitié MA, Mettens P, Moris P, Sadoff JC, Hawkridge A, Hussey GD, Mahomed H, Ofori-Anyinam O, Hanekom WA.

Am J Respir Crit Care Med. 2013 Aug 15;188(4):492-502. doi: 10.1164/rccm.201208-1385OC.

36.

Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.

Obiero J, Mwethera PG, Hussey GD, Wiysonge CS.

BMC Infect Dis. 2012 Nov 6;12:289. doi: 10.1186/1471-2334-12-289. Review.

37.

Predictive value of recent QuantiFERON conversion for tuberculosis disease in adolescents.

Machingaidze S, Verver S, Mulenga H, Abrahams DA, Hatherill M, Hanekom W, Hussey GD, Mahomed H.

Am J Respir Crit Care Med. 2012 Nov 15;186(10):1051-6. doi: 10.1164/rccm.201206-1134OC. Epub 2012 Sep 6.

PMID:
22955316
38.

Advances in childhood immunisation in South Africa: where to now? Programme managers' views and evidence from systematic reviews.

Wiysonge CS, Ngcobo NJ, Jeena PM, Madhi SA, Schoub BD, Hawkridge A, Shey MS, Hussey GD.

BMC Public Health. 2012 Jul 31;12:578. doi: 10.1186/1471-2458-12-578. Review.

39.

SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosis.

Hanekom WA, Hawkridge A, Mahomed H, Scriba TJ, Tameris M, Hughes J, Hatherill M, Day CL, Hussey GD.

S Afr Med J. 2012 Mar 2;102(6):438-41.

PMID:
22668930
40.

Health activism in Cape Town: a case study of the Health Workers Society.

Pick W, Claassen JW, Le Grange CA, Hussey GD.

S Afr Med J. 2012 Mar 2;102(6):403-305.

PMID:
22668919
41.

Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis.

Wiysonge CS, Uthman OA, Ndumbe PM, Hussey GD.

PLoS One. 2012;7(5):e37905. doi: 10.1371/journal.pone.0037905. Epub 2012 May 25.

42.

A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis-infected adults.

Scriba TJ, Tameris M, Smit E, van der Merwe L, Hughes EJ, Kadira B, Mauff K, Moyo S, Brittain N, Lawrie A, Mulenga H, de Kock M, Makhethe L, Janse van Rensburg E, Gelderbloem S, Veldsman A, Hatherill M, Geldenhuys H, Hill AV, Hawkridge A, Hussey GD, Hanekom WA, McShane H, Mahomed H.

Am J Respir Crit Care Med. 2012 Apr 1;185(7):769-78. doi: 10.1164/rccm.201108-1548OC. Epub 2012 Jan 26.

43.

'Communicate to vaccinate' (COMMVAC). building evidence for improving communication about childhood vaccinations in low- and middle-income countries: protocol for a programme of research.

Lewin S, Hill S, Abdullahi LH, de Castro Freire SB, Bosch-Capblanch X, Glenton C, Hussey GD, Jones CM, Kaufman J, Lin V, Mahomed H, Rhoda L, Robinson P, Waggie Z, Willis N, Wiysonge CS.

Implement Sci. 2011 Dec 2;6:125. doi: 10.1186/1748-5908-6-125.

44.

The African Vaccine-Preventable Diseases Network: a vaccine advocacy initiative.

Wiysonge CS, Armah GE, Madhi SA, Were F, Kitaka SB, Akoua-Koffi C, Gresenguet G, Gatheru Z, Maranga PW, Dicko A, Falade AG, Boula AY, Kuit SB, Odusanya OO, Sow PS, Lakhani N, Mpabalwani EM, Tamfum JJ, Hussey GD.

Pan Afr Med J. 2011;8:24. Epub 2011 Mar 14.

45.

Developing vaccinology expertise for Africa: six years and counting.

Wiysonge CS, Waggie Z, Mahomed H, Hawkridge A, Hatherill M, Hanekom WA, Hussey GD.

Vaccine. 2011 Aug 11;29(35):5821-3. doi: 10.1016/j.vaccine.2011.06.054. Epub 2011 Jun 28.

PMID:
21718743
46.

Use of systematic reviews in WHO recommendations.

Wiysonge CS, Hussey GD.

Lancet. 2011 Jun 11;377(9782):2006. doi: 10.1016/S0140-6736(11)60867-2. No abstract available.

PMID:
21665038
47.

Dose-finding study of the novel tuberculosis vaccine, MVA85A, in healthy BCG-vaccinated infants.

Scriba TJ, Tameris M, Mansoor N, Smit E, van der Merwe L, Mauff K, Hughes EJ, Moyo S, Brittain N, Lawrie A, Mulenga H, de Kock M, Gelderbloem S, Veldsman A, Hatherill M, Geldenhuys H, Hill AV, Hussey GD, Mahomed H, Hanekom WA, McShane H.

J Infect Dis. 2011 Jun 15;203(12):1832-43. doi: 10.1093/infdis/jir195.

PMID:
21606542
48.

The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa.

Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, Ehrlich R, Hanekom WA, Hussey GD.

PLoS One. 2011 Mar 29;6(3):e17984. doi: 10.1371/journal.pone.0017984. Erratum in: PLoS One. 2011;6(6). doi:10.1371/annotation/b371be66-de38-4ed6-b440-d27c9d7e552c.

49.

HIV-specific gag responses in early infancy correlate with clinical outcome and inversely with viral load.

Nqoko B, Day CL, Mansoor N, De Kock M, Hughes EJ, Hawkridge T, Kaplan G, Boom WH, Hussey GD, Hanekom WA.

AIDS Res Hum Retroviruses. 2011 Dec;27(12):1311-6. doi: 10.1089/aid.2011.0081. Epub 2011 May 12.

50.

Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa.

Mahomed H, Hawkridge T, Verver S, Geiter L, Hatherill M, Abrahams DA, Ehrlich R, Hanekom WA, Hussey GD; SATVI Adolescent Study Team.

Int J Tuberc Lung Dis. 2011 Mar;15(3):331-6.

PMID:
21333099

Supplemental Content

Loading ...
Support Center